Xiaojun Ji

Head of Translational Medicine at Nanjing Chia-Tai Tianqing Pharmaceutical Company

Presenter

Nanjing Chia-Tai Tianqing Pharmaceutical Company (NJCTTQ), was jointly founded by CP Group, a Thai company and Jiangsu Nongken Group. NJCTTQ specializes in research and development, production and commercialization of drugs for cardiovascular diseases, tumors, tumors supportive care, perioperative care, gastrointestinal disorders and contrast agents. We have more than 10 innovative programs, covering areas such as breast cancer, IgAN, PNH, acromegaly and etc for out-licensing. We also welcome opportunities for in-licensing projects. We embrace various models of cooperation